Deterioration of executive functioning in chronic ecstasy users; evidence for multiple drugs effects
- PMID: 21054259
- DOI: 10.2174/1874473711003030129
Deterioration of executive functioning in chronic ecstasy users; evidence for multiple drugs effects
Abstract
A quantitative meta-analysis was carried out on the chronic effects of ecstasy use on working memory (WM), assumed to consist of a central executive (CE) and four executive subcomponents: Updating, Attention shifting, Inhibition and Access to long term memory. Publications dating from January 1998 to January 2008 were only included when they fulfilled the criteria for a meta-analysis (number of subjects, means and standard deviations) and when polydrug users were used as controls. In addition, we also determined effect sizes for lifetime consumption differences between the groups of other psycho-active substances than ecstasy. Both Lifetime Total Ecstasy Consumption (LTEC) and the effect sizes for alcohol, nicotine, amphetamine, cocaine and lysergic acid diethylamide (LSD) were regressed on the mean effect sizes (mES) of the WM subcomponents in order to study dose-response relationships. Ecstasy users appeared to score significantly lower on the subcomponents Updating, Attention shifting and Access to long term memory, but not on Inhibition. We did not find significant regressions of LTEC on any of the executive functioning subcomponents mES values. Ecstasy users also consumed significantly more amphetamine, cocaine, alcohol, nicotine and LSD, but less alcohol than polydrug controls. However, also for these drugs no indications were found for a dose-response relationship with executive functioning.
Similar articles
-
Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.Psychol Med. 2008 Sep;38(9):1309-17. doi: 10.1017/S0033291707002140. Epub 2007 Nov 8. Psychol Med. 2008. PMID: 17988417
-
Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls.Psychopharmacology (Berl). 2007 Oct;194(3):371-9. doi: 10.1007/s00213-007-0837-5. Epub 2007 Jul 1. Psychopharmacology (Berl). 2007. PMID: 17605005
-
Ecstasy (MDMA) and memory function: a meta-analytic update.Hum Psychopharmacol. 2007 Aug;22(6):381-8. doi: 10.1002/hup.857. Hum Psychopharmacol. 2007. PMID: 17621368
-
Executive working memory deficits in abstinent ecstasy/MDMA users: a critical review.Neuropsychobiology. 2009;60(3-4):159-75. doi: 10.1159/000253552. Epub 2009 Nov 5. Neuropsychobiology. 2009. PMID: 19893333 Review.
-
Differential effects of ecstasy on short-term and working memory: a meta-analysis.Neuropsychol Rev. 2010 Mar;20(1):21-32. doi: 10.1007/s11065-009-9124-z. Epub 2010 Feb 16. Neuropsychol Rev. 2010. PMID: 20157852 Review.
Cited by
-
Let's Open the Decision-Making Umbrella: A Framework for Conceptualizing and Assessing Features of Impaired Decision Making in Addiction.Neuropsychol Rev. 2019 Mar;29(1):27-51. doi: 10.1007/s11065-018-9387-3. Epub 2018 Oct 6. Neuropsychol Rev. 2019. PMID: 30293096 Review.
-
3,4-methylenedioxymethamphetamine (MDMA): current perspectives.Subst Abuse Rehabil. 2013 Nov 21;4:83-99. doi: 10.2147/SAR.S37258. eCollection 2013. Subst Abuse Rehabil. 2013. PMID: 24648791 Free PMC article. Review.
-
The Psychedelic Renaissance: A Catholic Perspective.Linacre Q. 2024 Sep 15:00243639241274818. doi: 10.1177/00243639241274818. Online ahead of print. Linacre Q. 2024. PMID: 39544399 Free PMC article.
-
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.J Psychopharmacol. 2013 Jan;27(1):28-39. doi: 10.1177/0269881112456611. Epub 2012 Nov 20. J Psychopharmacol. 2013. PMID: 23172889 Free PMC article. Clinical Trial.
-
On the measurement of the effects of alcohol and illicit substances on inhibition of return.Psychopharmacology (Berl). 2012 Jun;221(4):541-50. doi: 10.1007/s00213-012-2725-x. Epub 2012 May 9. Psychopharmacology (Berl). 2012. PMID: 22569816 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous